晚期妇科卵巢肿瘤细胞减灭术中膈肌切除的手术结局:随机单中心临床试验DRAGON
该单中心前瞻性随机试验将88例接受单侧膈肌切除的卵巢癌患者1:1分为术中放置胸腔引流管组(A组)与未放置组(B组),发现A组严重呼吸道症状和中等/大量胸腔积液发生率均低于B组,多变量分析显示B组因胸腔积液需术后放置胸腔引流管的风险更高。
要点
- 术中放置胸腔引流管可降低膈肌切除术后严重呼吸道症状发生率(6.8% vs 22.7%)。
- 术中放置胸腔引流管可降低中等/大量胸腔积液发生率(18.2% vs 65.9%)。
- 未放置胸腔引流管组因胸腔积液需术后放置引流管的风险更高(OR=14.5)。
核心结论
- 膈肌切除术后术中放置胸腔引流管可有效预防术后胸部并发症。
- 切除范围不影响结局,术后胸腔穿刺或胸腔引流管放置的风险仍较高。
研究设计与样本
- 单中心前瞻性随机试验,筛查371例,纳入88例卵巢癌患者,1:1随机分为A组(术中放置胸腔引流管,44例)和B组(未放置胸腔引流管,44例),均接受单侧膈肌切除。
主要发现
- 术中并发症发生率两组差异无统计学意义(p=0.291)。
- 任何级别术后并发症发生率两组差异无统计学意义(p=0.072)。
- A组6.8%患者出现严重呼吸道症状,B组为22.7%(p=0.035)。
- A组18.2%患者出现中等/大量胸腔积液,B组为65.9%(p<0.0001)。
- 多变量分析显示,B组因胸腔积液需术后放置胸腔引流管的风险高于A组(OR=14.5,95%CI 3.7-57.4)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Ovarian cancer (OC) represent nearly 4% of gynecologic malignancies and it is often diagnosed at advanced stage. Diaphragmatic surgery, a fundamental step of advanced stage ovarian cancer (ASOC) debulking surgery, is associated with a high post-operative complication incidence, which is supposedly reduced with thoracostomy tube placement. We assessed the role of intra-operative thoracostomy tube placement, as a prevention measure for post-operative complications, after diaphragmatic resection. METHODS: This was a single center prospective randomized trial. Ovarian cancer patients, who underwent mono-lateral diaphragmatic resection, were randomized 1:1 into two arms. Arm A included patients receiving intra-operative thoracostomy tube placement (TP); Arm B patients did not receive thoracostomy tube placement (NTP). After surgery, all patients underwent seriate chest x-ray and ultrasound to record thoracic complications. Statistical analysis included uni- and multivariable logistic regression model (proportional odds model). RESULTS: Three hundred seventy-one patients were screened and 88 patients were enrolled: 44 in arm A and B, respectively. No statistically significant differences for intra-operative (p = 0.291) and any grade of post-operative complication (p = 0.072) were detected, while 6.8% of patients in arm A and 22.7% in arm B experienced severe respiratory symptoms (p = 0.035); 18.2% of patients in arm A had a moderate/large pleural effusion versus 65.9% in arm B (p < 0.0001). At multivariable analysis, results confirmed that the NTP-group had a higher risk to receive post-operative thoracostomy tube placement due to pleural effusion than the TP-group (odds ratio [95% Confidence Interval] = 14.5 [3.7-57.4]). CONCLUSIONS: Thoracostomy intra-operative tube placement after diaphragmatic resection is effective to prevent post-operative thoracic complications. The extension of resection does not influence outcomes and the risk of post-operative thoracentesis or TP remain elevated.
引用
- Cianci S, Fedele C, Vizzielli G, et al. Surgical outcomes of diaphragmatic resection during cytoreductive surgery for advanced gynecological ovarian neoplasia: A randomized single center clinical trial - DRAGON. Gynecol Oncol. 2021. PMID: 34844774. doi:10.1016/j.ygyno.2021.11.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。